Search

everythinglearnresearchcommunity

for

Search:↓

Increased EGFR gene variations may predict chemotherapy outcomes in small cell lung cancer patients.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

Childhood and adult height, and early immune-related hospitalizations increase testicular cancer risk, while baldness, larger families, and sports reduce it.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

The modified wash test is better than TrichoScan® for diagnosing hair loss.

rwSALT accurately measures hair regrowth in alopecia areata using scalp photos.

Adding chemotherapy to tamoxifen improves survival for older breast cancer patients with positive nodes.

The study found that different criteria led to different patient groups in the CombAT study compared to the MTOPS study.

Aumolertinib is effective and well-tolerated for treating advanced lung cancer with EGFR mutations.

The European Society of Cutaneous Lupus Erythematosus created a questionnaire to standardize patient assessment and improve care for cutaneous lupus.

RC48 shows promise for treating certain advanced cancers, but more research is needed.

Radiation therapy in breast cancer patients changes gene expression related to DNA damage, fibroblast growth, and hair follicle development, which could help improve treatment for radiation-induced fibrosis.

Topical calcitriol was safe and well-tolerated for potential hair loss prevention in chemotherapy patients.

CT scans can find serious prostate cancer even when PSA levels are low.

The Spanish HSS-29 scale effectively measures changes in life quality due to female-pattern hair loss.

Treat limited stage small cell lung cancer with chemotherapy and radiation, and consider preventive brain radiation for better survival chances.

Triptolide effectively and safely reduces actinic keratosis lesions in mice.

The combination therapy is effective and well-tolerated for treating esophageal cancer.

Disease-specific tools better assess alopecia areata's impact on quality of life.

The treatment showed high response rates and was well-tolerated, potentially extending patient survival.

Men with testicular cancer were less likely to experience baldness and severe acne.

The Spanish version of the Hair Specific Skindex-29 scale is a reliable and valid way to measure the impact of hair loss on women's quality of life.

ATR04-484 ointment shows promise for treating skin issues from cancer therapies.

More research is needed to understand chemotherapy-induced hair loss and its phases.

Total skin electron therapy is an effective treatment for mycosis fungoides, balancing effectiveness and side effects.

Recognizing RSCC is crucial due to its aggressive nature and high risk of poor outcomes.